Search for other papers by A C Paepegaey in
Google Scholar
PubMed
Search for other papers by M Coupaye in
Google Scholar
PubMed
Search for other papers by A Jaziri in
Google Scholar
PubMed
Search for other papers by F Ménesguen in
Google Scholar
PubMed
Search for other papers by B Dubern in
Google Scholar
PubMed
Search for other papers by M Polak in
Google Scholar
PubMed
Search for other papers by J M Oppert in
Google Scholar
PubMed
Search for other papers by M Tauber in
Google Scholar
PubMed
Search for other papers by G Pinto in
Google Scholar
PubMed
INSERM, UMRS 1166, Nutriomic Group 6, Paris, France
Sorbonne Université, UMRS1166, Paris, France
Search for other papers by C Poitou in
Google Scholar
PubMed
Introduction Prader–Willi syndrome (PWS) is a complex developmental genetic disorder including obesity with hyperphagia, psychiatric disturbances, endocrine and metabolic disorders ( 1 , 2 ). Global incidence has been recently evaluated as 1
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK
Search for other papers by M Guftar Shaikh in
Google Scholar
PubMed
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
Search for other papers by Timothy G Barrett in
Google Scholar
PubMed
Search for other papers by Nicola Bridges in
Google Scholar
PubMed
Search for other papers by Robin Chung in
Google Scholar
PubMed
Centre for Endocrinology, William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, London, UK
Search for other papers by Evelien F Gevers in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
Search for other papers by Anthony P Goldstone in
Google Scholar
PubMed
Search for other papers by Anthony Holland in
Google Scholar
PubMed
Search for other papers by Shankar Kanumakala in
Google Scholar
PubMed
Search for other papers by Ruth Krone in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Makarios Children's Hospital, Nicosia, Cyprus
Search for other papers by Andreas Kyriakou in
Google Scholar
PubMed
Sussex Community NHS Trust, Brighton, UK
Search for other papers by E Anne Livesey in
Google Scholar
PubMed
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK
Search for other papers by Angela K Lucas-Herald in
Google Scholar
PubMed
Search for other papers by Christina Meade in
Google Scholar
PubMed
Search for other papers by Susan Passmore in
Google Scholar
PubMed
The University of Dublin, Trinity College Dublin, Dublin, Republic of Ireland
Search for other papers by Edna Roche in
Google Scholar
PubMed
Search for other papers by Chris Smith in
Google Scholar
PubMed
Search for other papers by Sarita Soni in
Google Scholar
PubMed
Introduction Prader–Willi syndrome (PWS) is a rare complex genetic disorder arising from the lack of expression of the paternally inherited imprinted genes on chromosome 15q11-q13. The most common causes are paternal deletion (65–70%) and
Search for other papers by Devis Pascut in
Google Scholar
PubMed
Search for other papers by Sofia Tamini in
Google Scholar
PubMed
Search for other papers by Silvia Bresolin in
Google Scholar
PubMed
Search for other papers by Pablo Giraudi in
Google Scholar
PubMed
Search for other papers by Giuseppe Basso in
Google Scholar
PubMed
Division of Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Search for other papers by Alessandro Minocci in
Google Scholar
PubMed
Search for other papers by Claudio Tiribelli in
Google Scholar
PubMed
Division of Auxology, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Search for other papers by Graziano Grugni in
Google Scholar
PubMed
Division of Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Division of Auxology, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Search for other papers by Alessandro Sartorio in
Google Scholar
PubMed
Introduction Prader–Willi syndrome (PWS) is a complex multisystem disorder due to the lack of expression of genes located on the paternal chromosome 15q11.2-q13. Together with Angelman syndrome, a totally different clinical condition, PWS is
Willem-Alexander Children’s Hospital, Department of Pediatrics, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by H Vlaardingerbroek in
Google Scholar
PubMed
Search for other papers by E L T van den Akker in
Google Scholar
PubMed
Search for other papers by A C S Hokken-Koelega in
Google Scholar
PubMed
-melanotropin; β-MSH, β-melanotropin. The aim of this review is to present data on the extreme ends of the obesity spectrum in patients with Prader–Willi syndrome (PWS), Bardet–Biedl syndrome (BBS), acquired hypothalamic obesity in craniopharyngioma
Search for other papers by Sakina Kherra in
Google Scholar
PubMed
Search for other papers by Wendy Forsyth Paterson in
Google Scholar
PubMed
Search for other papers by Filiz Mine Cizmecioglu in
Google Scholar
PubMed
Search for other papers by Jeremy Huw Jones in
Google Scholar
PubMed
Search for other papers by Mariam Kourime in
Google Scholar
PubMed
Search for other papers by Heba Hassan Elsedfy in
Google Scholar
PubMed
Search for other papers by Sameh Tawfik in
Google Scholar
PubMed
Search for other papers by Andreas Kyriakou in
Google Scholar
PubMed
Search for other papers by Mohamad Guftar Shaikh in
Google Scholar
PubMed
Search for other papers by Malcolm David Cairns Donaldson in
Google Scholar
PubMed
Introduction The Prader–Willi syndrome (PWS) results from the absence of paternally imprinted genes in the 15q 11–13 region, caused by a deletion in the paternal chromosome (del15q) in 70% of cases and disomy of the maternal chromosome (mUPD15
Search for other papers by Christine Poitou in
Google Scholar
PubMed
Search for other papers by Anthony Holland in
Google Scholar
PubMed
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Laura C G de Graaff in
Google Scholar
PubMed
Search for other papers by Sandrine Bottius in
Google Scholar
PubMed
Search for other papers by Berit Otterlei in
Google Scholar
PubMed
Search for other papers by Maithé Tauber in
Google Scholar
PubMed
Introduction Prader–Willi syndrome (PWS) is a complex neurodevelopmental genetic disorder including obesity consequent upon hyperphagia, psychiatric disturbances, endocrine and metabolic disorders ( 2 ). Global incidence is approximately 1 in
Search for other papers by Régis Coutant in
Google Scholar
PubMed
Pediatric team of the Clinical Investigation Center 9302/INSERM, Hospital of Children, Toulouse, France
Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Toulouse, France
Search for other papers by Maithé Tauber in
Google Scholar
PubMed
Search for other papers by Béatrice Demaret in
Google Scholar
PubMed
Search for other papers by Robin Henocque in
Google Scholar
PubMed
Search for other papers by Yves Brault in
Google Scholar
PubMed
Search for other papers by François Montestruc in
Google Scholar
PubMed
Patient-Reported Outcomes Unit (PROQOL), UMR 1123, University Paris Cité, INSERM, Paris, France
Search for other papers by Olivier Chassany in
Google Scholar
PubMed
Search for other papers by Michel Polak in
Google Scholar
PubMed
Search for other papers by the QOLITHOR Study Group in
Google Scholar
PubMed
insufficiency as part of multiple pituitary hormone deficiencies as well as other conditions (small for gestational age (SGA), Prader–Willi syndrome (PWS), Turner syndrome, or chronic renal failure). Pediatric patients on hormonal replacement therapy for other
Search for other papers by Anita Hokken-Koelega in
Google Scholar
PubMed
Search for other papers by Aart-Jan van der Lely in
Google Scholar
PubMed
Search for other papers by Berthold Hauffa in
Google Scholar
PubMed
Search for other papers by Gabriele Häusler in
Google Scholar
PubMed
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Search for other papers by Mohamad Maghnie in
Google Scholar
PubMed
Search for other papers by Jesús Argente in
Google Scholar
PubMed
Search for other papers by Jean DeSchepper in
Google Scholar
PubMed
Search for other papers by Helena Gleeson in
Google Scholar
PubMed
Search for other papers by John W Gregory in
Google Scholar
PubMed
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Fahrettin Keleştimur in
Google Scholar
PubMed
Search for other papers by Anton Luger in
Google Scholar
PubMed
Search for other papers by Hermann L Müller in
Google Scholar
PubMed
Search for other papers by Sebastian Neggers in
Google Scholar
PubMed
Search for other papers by Vera Popovic-Brkic in
Google Scholar
PubMed
Search for other papers by Eleonora Porcu in
Google Scholar
PubMed
Search for other papers by Lars Sävendahl in
Google Scholar
PubMed
Search for other papers by Stephen Shalet in
Google Scholar
PubMed
Search for other papers by Bessie Spiliotis in
Google Scholar
PubMed
Search for other papers by Maithé Tauber in
Google Scholar
PubMed
deficiency (CO-GHD), those born small for gestational age (SGA), girls with Turner syndrome (TS), patients with Prader–Willi syndrome (PWS), and survivors of cancers treated during childhood was addressed and, specifically, the role for GH therapy in patients
Search for other papers by Lukas Plachy in
Google Scholar
PubMed
Search for other papers by Lenka Petruzelkova in
Google Scholar
PubMed
Search for other papers by Petra Dusatkova in
Google Scholar
PubMed
Search for other papers by Klara Maratova in
Google Scholar
PubMed
Search for other papers by Dana Zemkova in
Google Scholar
PubMed
Search for other papers by Lenka Elblova in
Google Scholar
PubMed
Search for other papers by Vit Neuman in
Google Scholar
PubMed
Search for other papers by Stanislava Kolouskova in
Google Scholar
PubMed
Search for other papers by Barbora Obermannova in
Google Scholar
PubMed
Search for other papers by Marta Snajderova in
Google Scholar
PubMed
Search for other papers by Zdenek Sumnik in
Google Scholar
PubMed
Search for other papers by Jan Lebl in
Google Scholar
PubMed
Search for other papers by Stepanka Pruhova in
Google Scholar
PubMed
Turner syndrome, Prader-Willi syndrome, and those with secondary causes of their short stature (e.g. chronic renal insufficiency and secondary GH deficiency due to intracranial tumor and/or irradiation), 528 children remained for further evaluation
Search for other papers by Metin Guclu in
Google Scholar
PubMed
Search for other papers by Sinem Kiyici in
Google Scholar
PubMed
Search for other papers by Zulfiye Gul in
Google Scholar
PubMed
Search for other papers by Sinan Cavun in
Google Scholar
PubMed
also remained low for up to 8 h following exenatide administration. Prader–Willi syndrome (PWS) is associated with hyperphagia and obesity. Patients with PWS have high circulating ghrelin levels that do not decrease postprandially ( 23 ). There are